Elevated Blood Bicarbonate Levels and Long-Term Adverse Outcomes in Patients with Chronic Heart Failure
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14900 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Tomofumi Misaka und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan. Hauptthemen laut MEDLINE: Heart Failure, Bicarbonates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science KAKENHI, Japan Society for the Promotion of Science.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
The bicarbonate (HCO3−) buffer system is crucial for maintaining acid–base homeostasis and blood pH. Recent studies showed that elevated serum HCO3− levels serve as an indicator of the beneficial effects of acetazolamide in improving decongestion in acute heart failure. In this study, we sought to clarify the clinical relevance and prognostic impact of HCO3− in chronic heart failure (CHF).
Methods
This cohort study enrolled 694 hospitalized patients with CHF (mean age 68.6 ± 14.6, 62% male) who underwent arterial blood sampling and exhibited neutral pH ranging from 7.35 to 7.45. We characterized the patients based on HCO3− levels and followed them to register cardiac events.
Results
Among the patients, 17.3% (120 patients) had HCO3− levels exceeding 26 mmol/L. Patients presenting HCO3− > 26 mmol/L were more likely to use loop diuretics and had higher serum sodium and lower potassium levels, but left ventricular ejection fraction did not differ compared with those with HCO3− between 22 and 26 (379 patients) or those with HCO3− < 22 mmol/L (195 patients). During a median follow-up period of 1950 days, Kaplan–Meier analysis revealed that patients with HCO3− > 26 mmol/L had the lowest event-free survival rate from either cardiac deaths or heart failure-related rehospitalization (P < 0.01 and 0.03, respectively). In the multivariable Cox model, the presence of HCO3− > 26 mmol/L independently predicted increased risks of each cardiac event with a hazard ratio of 2.31 and 1.69 (P < 0.01 and 0.02, respectively), while HCO3− < 22 mmol/L was not associated with these events (hazard ratios, 0.99 and 1.19; P = 0.98 and 0.43, respectively).
Conclusions
Elevated blood HCO3− levels may signify enhanced proximal nephron activation and loop diuretic resistance, leading to long-term adverse outcomes in patients with CHF, even within a normal pH range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
- Department of Community Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
- Department of Clinical Laboratory Sciences, Fukushima Medical University School of Health Sciences, Fukushima, Japan.
ORCID-Profile: Tomofumi Misaka
Förderung
- Japan Society for the Promotion of Science KAKENHI
- Japan Society for the Promotion of Science
Zitieren
APA
Misaka, T., Sato, Y., Sugawara, Y., Ogawara, R., Ichimura, S., Tomita, Y., Anzai, F., Yokokawa, T., Sato, A., Shimizu, T., Sato, T., Oikawa, M., Kobayashi, A., Yoshihisa, A., & Takeishi, Y. (2024). Elevated Blood Bicarbonate Levels and Long-Term Adverse Outcomes in Patients with Chronic Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.14900
Vancouver
Misaka T, Sato Y, Sugawara Y, Ogawara R, Ichimura S, Tomita Y, et al. Elevated Blood Bicarbonate Levels and Long-Term Adverse Outcomes in Patients with Chronic Heart Failure. ESC Heart Failure. 2024. doi:10.1002/ehf2.14900
BibTeX
@article{Misaka2024,
author = {Misaka, Tomofumi and Sato, Yu and Sugawara, Yukiko and Ogawara, Ryo and Ichimura, Shohei and Tomita, Yusuke and Anzai, Fumiya and Yokokawa, Tetsuro and Sato, Akihiko and Shimizu, Takeshi and Sato, Takamasa and Oikawa, Masayoshi and Kobayashi, Atsushi and Yoshihisa, Akiomi and Takeishi, Yasuchika},
title = {Elevated Blood Bicarbonate Levels and Long-Term Adverse Outcomes in Patients with Chronic Heart Failure},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14900}
}
EUVIMED